Olema Pharmaceuticals (OLMA) Receivables - Accured (2021 - 2026)
Olema Pharmaceuticals' Receivables - Accured came in at $2.85 million for Q2 2026, up 55.9% from $1.83 million a year earlier but down 14.2% from the prior quarter.
Powered by 
Analysis
Olema Pharmaceuticals (OLMA) Receivables - Accured (2021 - 2026) Analysis & Trends
At the end of FY2025, Olema Pharmaceuticals' Receivables - Accured was $3.14 million, up 48.0% from FY2024.
- Receivables - Accured has increased in each of the last four years, with a four-year compound annual growth rate of 121.6% (FY2021 to FY2025).
- Going back by year, Receivables - Accured was $2.12 million in FY2024 (+215.0%), $673,000 in FY2023 (+111.0%), $319,000 in FY2022 (+145.4%) and $130,000 in FY2021.
- The five-year range for quarterly Receivables - Accured is $130,000 (Q4 2021) to $3.32 million (Q1 2026).
- Year-over-year, Receivables - Accured has increased for 11 consecutive quarters, with growth averaging 120.8% over the last eight quarters.
- The fastest year-over-year change in Receivables - Accured over five years came in Q2 2024 (growth of 271.5%), and the weakest in Q3 2023 (a decline of 8.3%).
- Business Quant data shows OLMA's Receivables - Accured at $3.32 million (Q1 2026), $3.14 million (Q4 2025) and $2.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Olema Pharmaceuticals | 752.96 Mn | 752.96 Mn | - | 2.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.85 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 687,000.00 |
| Jun 30, 2024 | 821,000.00 |
| Mar 31, 2024 | 664,000.00 |
| Dec 31, 2023 | 673,000.00 |
| Sep 30, 2023 | 419,000.00 |
| Jun 30, 2023 | 221,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 319,000.00 |
| Sep 30, 2022 | 457,000.00 |
| Dec 31, 2021 | 130,000.00 |
API Access
Olema Pharmaceuticals Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=OLMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "OLMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=OLMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();